Merck KGaA’s lupus drug to advance to Phase III despite mixed data
While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary endpoint.
22 May 2025
22 May 2025
While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary endpoint.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.